Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Diffuse Intrinsic Pontine Glioma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Obesity 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Glioma 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Disease 1Carcinosarcoma 1

Interventions

Temozolomide 3Radiotherapy 3TIC10 compound 2Everolimus 2spartalizumab 1ribociclib 1olutasidenib 1lutetium Lu 177 dotatate 1lorlatinib 1larotrectinib 1etoposide phosphate 1balstilimab 1Vaccines 1Standard of Care 1Specimen Handling 1Proto-Oncogene Proteins c-akt 1Phosphatidylinositol 3-Kinases 1Ipilimumab 1Injections 1Immune Checkpoint Inhibitors 1GDC-0084 1Fluid Therapy 1Etoposide 1Eflornithine 1Diphtheria-Tetanus Vaccine 1Cetuximab 1CBLC137 1Biopsy 1Bevacizumab 1Automobiles 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Diffuse Intrinsic Pontine Glioma × TIC10 compound × Clear all
NCT05476939 2026-02-05

BIOMEDE 2

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Recruiting
433 enrolled
CNS

Diffuse Intrinsic Pontine Glioma

NCT05009992 2025-12-17

PNOC022

University of California, San Francisco

Phase 2 Recruiting
360 enrolled
CNS

Diffuse Intrinsic Pontine Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡